Collaboration Details

Print  Close


Title of Collaborative Activity:

A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of escalating multiple oral doses of AG-348 in subjects with stable sickle cell disease

Description of Collaborative Activity:

A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of escalating multiple oral doses of AG-348 in subjects with stable sickle cell disease

Type of Collaborative Activity:

Research Initiative

Year the Collaborative Activity Originated:

NIH Participating Institutes/Centers/Office of the Director:

NHLBI

HHS Agency Collaborators on this Activity:

FDA